CRM Software and Service Sales Executive Joins Growing Droplets Team; MacIsaac Brings Wealth of Experience with CRM and Internet Software Solutions for Fortune 1000 Clients.Business/Technology Editors NEW YORK--(BUSINESS WIRE)--Feb. 7, 2001 Internet software infrastructure company Droplet, Inc. today announced the appointment of Thomas MacIsaac as Vice President of Sales. He joins a growing management team of experienced executives from Fort Point Partners, Giga Information Group and IBM (International Business Machines Corporation, Armonk, NY, www.ibm.com) The world's largest computer company. IBM's product lines include the S/390 mainframes (zSeries), AS/400 midrange business systems (iSeries), RS/6000 workstations and servers (pSeries), Intel-based servers (xSeries) . "Thomas will be the key driver in our efforts to pursue opportunities in the areas of enterprise-class applications and Internet solutions. He has a strong, consistent track record of selling software solutions and services to Fortune 1000 companies, who are key benefactors of Droplets technology." said Philip Brittan, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Droplet, Inc. MacIsaac comes to Droplet Inc. from ONE Inc. with an extensive background in providing solutions that deliver both operational efficiencies and forge deeper customer relationships. ONE is a national systems integration firm partnering with Pivotal (Nasdaq:PVTL), Siebel (Nasdaq:SEBL SEBL Siebel Systems, Inc. (stock abbreviation, AMEX) ), ATG ATG antithymocyte globulin. lymphocyte immune globulin (antithymocyte globulin equine, ATG, ATG equine, LIG) Atgam Pharmacologic class: Immunoglobulin Therapeutic class: Immunosuppressant (Nasdaq:ARTG ARTG Australian Register of Therapeutic Goods ), Silverstream (Nasdaq:SSSW), BEA (Nasdaq:BEAS), iPlanet (Nasdaq:SUNW SUNW Sun Microsystems, Inc (former stock symbol; now JAVA) SUNW Stanford University Network Workstation (Sun Microsystems, Inc) ), Vignette (Nasdaq: VIGN VIGN Vignette Corporation (stock abbreviation, AMEX) ), e.Piphany (Nasdaq:EPNY) and Vitria (Nasdaq:VITR VITR Vitria Technologies (stock symbol) VITR Visible and Thermal Infrared Radiometer ). While at ONE, Inc. MacIsaac was responsible for clients such as Pfizer (NYSE NYSE See: New York Stock Exchange :PFE), ING Barrings (NYSE:ING), Goldman Sachs (NYSE:GS), Comedy Central (NYSE:VIA), HarperCollins (NYSE: NWS), and Multex.Com (Nasdaq:MLTX). "I see the Droplets platform as the evolutionary convergence of existing Win32 client server computing and new Web-based applications. This technology will enable businesses to leverage existing IT investments while at the same time provide them a vehicle to deliver next generation solutions to customers, employees and partners. Ultimately, this will change the way people view the Web." MacIsaac joins a growing team of seasoned technology executives including development and process manager Johanna Voolich, formerly with Fort Point Partners, director of business development Christopher Fallon, formerly with Giga Information Group (Nasdaq:GIGX), and director of marketing communications William Power, formerly with IBM Corp. (NYSE:IBM). About Droplet, Inc. Droplet, Inc. is an Internet infrastructure company that gives software vendors, consulting firms and Web developers the ability to create the first true "direct-connect" applications that can be delivered as part of Web pages and dragged to the users' desktops. Droplets represent the only convergent technology to deliver the end user experience and performance of locally installed software together with all the administrative and deployment benefits of Net or Web-based applications. The company licenses its patent-pending technology for businesses to create and deploy Droplets(TM) in Java or C++, and it licenses various ready-made Droplets applications and solutions to businesses. For more information, go to www.droplets.com. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion